Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
36
BME Quote, Financials, Valuation and Earnings
Last price:
$37.57
Seasonality move
:
-1.88%
Day range:
$36.92 - $38.29
52-week range:
$36.87 - $42.86
Dividend yield:
0.42%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
107.5K
Avg. volume:
61K
1-year change:
-4.07%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
$37.44 | -- | -- | -- | $0.26 | 0.42% | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.74 | -- | -- | -- | $0.18 | 1.2% | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
$32.31 | -- | -- | -- | $0.18 | 0.55% | -- |
|
HQH
abrdn Healthcare Investors
|
$16.29 | -- | -- | -- | $0.62 | 0% | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
$18.71 | -- | -- | -- | $0.36 | 10.82% | -- |
|
THW
Tekla World Healthcare Fund
|
$10.99 | -- | -- | -- | $0.12 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | 0.916 | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.543 | -- | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | 1.154 | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | 1.083 | -- | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | 0.976 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 0.694 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- | -- |
|
THQ
Tekla Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
Blackrock Health Sciences Trust vs. Competitors
-
Which has Higher Returns BME or BMEZ?
BlackRock Health Sciences Trust II has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat BlackRock Health Sciences Trust II's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- -
What do Analysts Say About BME or BMEZ?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust II has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than BlackRock Health Sciences Trust II, analysts believe Blackrock Health Sciences Trust is more attractive than BlackRock Health Sciences Trust II.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 BMEZBlackRock Health Sciences Trust II0 0 0 -
Is BME or BMEZ More Risky?
Blackrock Health Sciences Trust has a beta of 0.680, which suggesting that the stock is 32.048% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust II has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BME or BMEZ?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 0.42%. BlackRock Health Sciences Trust II offers a yield of 1.2% to investors and pays a quarterly dividend of $0.18 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. BlackRock Health Sciences Trust II pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or BMEZ?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust II quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than BlackRock Health Sciences Trust II's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while BlackRock Health Sciences Trust II's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for BlackRock Health Sciences Trust II. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- --
-
Which has Higher Returns BME or GDOC?
Goldman Sachs Future Health Care Equity ETF has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Goldman Sachs Future Health Care Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -
What do Analysts Say About BME or GDOC?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Goldman Sachs Future Health Care Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Goldman Sachs Future Health Care Equity ETF, analysts believe Blackrock Health Sciences Trust is more attractive than Goldman Sachs Future Health Care Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 -
Is BME or GDOC More Risky?
Blackrock Health Sciences Trust has a beta of 0.680, which suggesting that the stock is 32.048% less volatile than S&P 500. In comparison Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BME or GDOC?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 0.42%. Goldman Sachs Future Health Care Equity ETF offers a yield of 0.55% to investors and pays a quarterly dividend of $0.18 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Goldman Sachs Future Health Care Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or GDOC?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Goldman Sachs Future Health Care Equity ETF quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Goldman Sachs Future Health Care Equity ETF's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Goldman Sachs Future Health Care Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Goldman Sachs Future Health Care Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- --
-
Which has Higher Returns BME or HQH?
abrdn Healthcare Investors has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat abrdn Healthcare Investors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- HQHabrdn Healthcare Investors-- -- -- -
What do Analysts Say About BME or HQH?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Investors has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than abrdn Healthcare Investors, analysts believe Blackrock Health Sciences Trust is more attractive than abrdn Healthcare Investors.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 HQHabrdn Healthcare Investors0 0 0 -
Is BME or HQH More Risky?
Blackrock Health Sciences Trust has a beta of 0.680, which suggesting that the stock is 32.048% less volatile than S&P 500. In comparison abrdn Healthcare Investors has a beta of 0.769, suggesting its less volatile than the S&P 500 by 23.068%.
-
Which is a Better Dividend Stock BME or HQH?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 0.42%. abrdn Healthcare Investors offers a yield of 0% to investors and pays a quarterly dividend of $0.62 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. abrdn Healthcare Investors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or HQH?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than abrdn Healthcare Investors quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than abrdn Healthcare Investors's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while abrdn Healthcare Investors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for abrdn Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- HQHabrdn Healthcare Investors-- -- -- --
-
Which has Higher Returns BME or THQ?
Tekla Healthcare Opportunities Fund has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Tekla Healthcare Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- THQTekla Healthcare Opportunities Fund-- -- -- -
What do Analysts Say About BME or THQ?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla Healthcare Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Tekla Healthcare Opportunities Fund, analysts believe Blackrock Health Sciences Trust is more attractive than Tekla Healthcare Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 THQTekla Healthcare Opportunities Fund0 0 0 -
Is BME or THQ More Risky?
Blackrock Health Sciences Trust has a beta of 0.680, which suggesting that the stock is 32.048% less volatile than S&P 500. In comparison Tekla Healthcare Opportunities Fund has a beta of 0.935, suggesting its less volatile than the S&P 500 by 6.506%.
-
Which is a Better Dividend Stock BME or THQ?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 0.42%. Tekla Healthcare Opportunities Fund offers a yield of 10.82% to investors and pays a quarterly dividend of $0.36 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Tekla Healthcare Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or THQ?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Tekla Healthcare Opportunities Fund quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Tekla Healthcare Opportunities Fund's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Tekla Healthcare Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Tekla Healthcare Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- THQTekla Healthcare Opportunities Fund-- -- -- --
-
Which has Higher Returns BME or THW?
Tekla World Healthcare Fund has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About BME or THW?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Tekla World Healthcare Fund, analysts believe Blackrock Health Sciences Trust is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is BME or THW More Risky?
Blackrock Health Sciences Trust has a beta of 0.680, which suggesting that the stock is 32.048% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.302%.
-
Which is a Better Dividend Stock BME or THW?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 0.42%. Tekla World Healthcare Fund offers a yield of 0% to investors and pays a quarterly dividend of $0.12 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or THW?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 1.41% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.28% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.38% over the past day.
